Neurocrine Biosciences Inc (NBIX)

Market price: $145.42

7 valuation methods

• EV / Revenue: $104.39 to $207.17 (midpoint $127.04)
• DCF (FCFF): $170.41 to $242.64 (midpoint $200.66)
• EV / EBITDA: $122.84 to $389.31 (midpoint $227.60)
• EV / Gross Profit: $183.11 to $388.12 (midpoint $251.86)
• P / B: $137.14 to $481.65 (midpoint $258.13)
• P / E: $135.81 to $462.70 (midpoint $272.74)
• P / E — adjusted: $166.13 to $468.38 (midpoint $317.61)